EUVIMEDEUVIMED entdecken
Crossref

ROF‐2 as an Aggregation‐Induced Emission (AIE) Probe for Multi‐Target Amyloid Detection and Screening of Amyloid Inhibitors

Yijing Tang, Dong Zhang, Jie Zheng iD

Small · 2024

DOI: 10.1002/smll.202400879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yijing Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biomolecular, and Corrosion Engineering, The University of Akron, Ohio, 44325, USA. Hauptthemen laut MEDLINE: Amyloid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Misfolding and aggregation of amyloid peptides into β‐structure‐rich fibrils represent pivotal pathological features in various neurodegenerative diseases, including Alzheimer's disease (AD), type II diabetes (T2D), and medullary thyroid carcinoma (MTC). The development of effective amyloid detectors and inhibitors for probing and preventing amyloid aggregation is crucial for diagnosing and treating debilitating diseases, yet it poses significant challenges. Here, an aggregation‐induced emission (AIE) molecule of ROF2 with multifaceted functionalities as an amyloid probe and a screening tool for amyloid inhibitors using different biophysical, cellular, and worm assays, are reported. As an amyloid probe, ROF2 outperformed ThT, demonstrating its superior sensing capability in monitoring, detecting, and distinguishing amyloid aggregates of different sequences (Amyloid‐β, human islet amyloid polypeptide, or human calcitonin) and sizes (monomers, oligomers, or fibrils). More importantly, the utilization of ROF2 as a screening molecule to identify and repurpose cardiovascular drugs as amyloid inhibitors is introduced. These drugs exhibit potent amyloid inhibition properties, effectively preventing amyloid aggregation and reducing amyloid‐induced cytotoxicity both in cells and nematode. The findings present a novel strategy to discovery AIE‐based amyloid probes and to be used to repurpose amyloid inhibitors, expanding diagnostic and therapeutic options for neurodegenerative diseases while addressing vascular congestion and amyloid aggregation risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidHumansProtein AggregatesAnimalsIslet Amyloid PolypeptideAmyloid beta-Peptides

Stichwörter der Autor:innen

amyloid peptidebiomarker sensordrug screeningneurodegenerative diseaseprotein aggregation

Substanzen

AmyloidProtein AggregatesIslet Amyloid PolypeptideAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Chemical, Biomolecular, and Corrosion Engineering, The University of Akron, Ohio, 44325, USA.

ORCID-Profile: Jie Zheng

Förderung

  • National Science Foundation

Zitieren

APA

Tang, Y., Zhang, D., & Zheng, J. (2024). ROF‐2 as an Aggregation‐Induced Emission (AIE) Probe for Multi‐Target Amyloid Detection and Screening of Amyloid Inhibitors. Small. https://doi.org/10.1002/smll.202400879

Vancouver

Tang Y, Zhang D, Zheng J. ROF‐2 as an Aggregation‐Induced Emission (AIE) Probe for Multi‐Target Amyloid Detection and Screening of Amyloid Inhibitors. Small. 2024. doi:10.1002/smll.202400879

BibTeX
@article{Tang2024,
  author = {Tang, Yijing and Zhang, Dong and Zheng, Jie},
  title = {ROF‐2 as an Aggregation‐Induced Emission (AIE) Probe for Multi‐Target Amyloid Detection and Screening of Amyloid Inhibitors},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202400879}
}
Kostenlos starten →